A detailed history of Private Capital Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Private Capital Group, LLC holds 440 shares of RGEN stock, worth $53,138. This represents 0.05% of its overall portfolio holdings.

Number of Shares
440
Previous 414 6.28%
Holding current value
$53,138
Previous $78,000 7.69%
% of portfolio
0.05%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

BUY
$140.68 - $188.02 $3,657 - $4,888
26 Added 6.28%
440 $72,000
Q1 2022

Apr 21, 2022

BUY
$161.19 - $257.96 $8,059 - $12,897
50 Added 13.74%
414 $78,000
Q4 2021

Jan 24, 2022

SELL
$247.59 - $304.47 $6,932 - $8,525
-28 Reduced 7.14%
364 $96,000
Q3 2021

Oct 13, 2021

SELL
$194.77 - $324.21 $3,505 - $5,835
-18 Reduced 4.39%
392 $113,000
Q2 2021

Jul 26, 2021

SELL
$165.87 - $220.95 $4,478 - $5,965
-27 Reduced 6.18%
410 $82,000
Q1 2021

Apr 12, 2021

SELL
$180.37 - $226.26 $1,442 - $1,810
-8 Reduced 1.8%
437 $85,000
Q4 2020

Jan 26, 2021

SELL
$148.08 - $206.57 $1,628 - $2,272
-11 Reduced 2.41%
445 $85,000
Q3 2020

Nov 12, 2020

SELL
$122.51 - $158.27 $4,165 - $5,381
-34 Reduced 6.94%
456 $67,000
Q2 2020

Aug 13, 2020

SELL
$94.33 - $140.48 $7,923 - $11,800
-84 Reduced 14.63%
490 $61,000
Q1 2020

May 07, 2020

SELL
$84.96 - $109.14 $8,496 - $10,914
-100 Reduced 14.84%
574 $55,000
Q3 2019

Nov 13, 2019

BUY
$76.65 - $95.51 $48,749 - $60,744
636 Added 1673.68%
674 $52,000
Q2 2019

Aug 15, 2019

SELL
$54.2 - $85.95 $37,018 - $58,703
-683 Reduced 94.73%
38 $2,000
Q1 2019

Apr 26, 2019

BUY
$49.45 - $62.8 $31,054 - $39,438
628 Added 675.27%
721 $43,000
Q4 2018

Jan 28, 2019

BUY
$48.26 - $68.88 $2,654 - $3,788
55 Added 144.74%
93 $5,000
Q4 2017

May 18, 2018

SELL
$32.53 - $38.92 $111,610 - $133,534
-3,431 Reduced 98.9%
38 $1,000
Q4 2017

Mar 07, 2018

BUY
$32.53 - $38.92 $112,846 - $135,013
3,469
3,469 $218,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.